OPRmax is a program created to help member practices earn additional discounts based on market share. Only practices that are interested in a particular initiative join.
Since this is an opt-in program and purely voluntary, members are much more interested in maximizing their contract and being compliant.
In the first initiative under OPRmax, Aloxi, the MGI anti-emetic was selected.
As we demonstrate how successful the voluntary program can be, we have additional market share proposals being evaluated.
Over a 12 month period, the total savings for those compliant with the Aloxi contract was $1,518,160.81 which included a 19% up front discount as well as rebate credits.
Find out how OPR can help you. Contact Us to learn more.